Philadelphia Hand To Shoulder Center Of Thomas Jefferson University Announces Prospective Study On AlloWrap In The Hand And Wrist

Philadelphia, Pa. — August 8, 2017 — Researchers at the Philadelphia Hand to Shoulder Center (PHSC) of Thomas Jefferson University (TJU) today announced the initiation of a prospective, randomized trial for the treatment of tendon adhesions of the hand and wrist using AlloSource’s AlloWrap® DS, a human amniotic membrane, in conjunction with tenolysis. The study, titled A Prospective Randomized Trial Comparing Use of AlloWrap® DS Surgical Barrier with Tenolysis versus Tenolysis Alone for Treatment of Tendon Adhesions of the Hand and Wrist, aims to identify the ideal method for treating tendon adhesions in the hand and wrist. The study will…

AlloSource Releases AlloFuse Line Extentsion

Company adds AlloFuse Select CM, a cellular allograft matrix, to the AlloFuse portfolio Centennial, Colo. — August 1, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue, and cellular allografts to advance patient healing in surgical procedures and wound care, today announced the release of AlloFuse® Select CM, a premium addition to AlloSource’s AlloFuse portfolio. AlloFuse Select CM combines osteoconductive, osteoinductive, and osteogenic properties to initiate and nurture bone growth, delivering the benefits of autograft bone without the potential drawbacks. The product is clinically proven to activate and support bone formation and can be used…

Cross-Country Bike Ride For Organ, Eye And Tissue Donation Kicking Off At AlloSource

Cross-Country Bike Ride For Organ, Eye And Tissue Donation Kicking Off At AlloSource

Centennial, Colo. — June 30, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures to advance patient healing, today hosted the kickoff event for Pedal For Life’s cross-country bike ride to raise awareness for organ, eye and tissue donation. The Pedal for Life team will ride from Centennial, Colorado to Iowa City, Iowa and stop at each organ procurement organization on the way to highlight the importance of donation. Pedal For Life started this year’s ride in Centennial because of the organization’s connection to AlloSource. Pedal For…

Stryker And AlloSource Announce Collaboration To Distribute Biologics For Use In Sports Medicine Procedures

Denver, Colorado, USA – May 18, 2017 – Today at the 2017 Annual Arthroscopy Association of North America (AANA) Meeting (booth #109), Stryker’s Sports Medicine business and AlloSource® formally announced their collaboration to provide high quality, innovative biologics for use in sports medicine procedures. This collaboration is driven by the companies’ combined commitment to better serve their customers, help patients in need and fully honor the gift of tissue donation. “We believe biologics will play a critical role in advancing the field of Sports Medicine, so we are very excited about the opportunity to collaborate with AlloSource given their history…

AlloSource’s Burn Skin AlloGraft Rebranded To Pureskin

Company to feature PureSkin at the American Burn Association Annual Meeting Centennial, Colo. — March 20, 2017 — AlloSource, one of the nation’s largest providers of burn skin, cartilage, bone, soft-tissue and cellular allografts for use in surgical procedures and burn and wound care to advance patient healing, will feature its PureSkin™ human skin allograft at the 49th American Burn Association Annual Meeting. AlloSource has been a longtime leader in providing skin allografts to help patients heal from burns, and its rebranded PureSkin allograft offers clinicians a temporary biological dressing for burn patients. The product is available in both cryopreserved…

Theracell And AlloSource Announce Second Patent For Bone Fiber Technology

Demineralized Bone Fiber (DBF™) patent to expand TheraCell’s osteobiologic patent portfolio Northridge, Cali. and Centennial, Colo. — March 9, 2017 — TheraCell, a regenerative medicine company, today announced it was awarded a second patent for its demineralized bone fiber (DBF™) technology by the United States Patent and Trademark Office. The addition of U.S. Patent Number 9,572,912, titled Demineralized bone fibers having controlled geometry and shapes and methods thereof, expands TheraCell’s intellectual property portfolio, demonstrating its ongoing commitment to innovation and leadership in the orthopedic allograft industry. TheraCell’s DBF™ technology is incorporated into two innovative demineralized cortical fiber allografts, AlloFuse® Cortical…

AlloSource Announces The Annual Dr. Steven Gitelis Inspiration Award

Company honors Dr. Brian Cole with the inaugural award Centennial, Colo. — January 24, 2017 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, announced the creation of the Dr. Steven Gitelis Inspiration Award. The award honors a doctor or clinician that inspires AlloSource through his or her work in treating patients with donated human allografts. Dr. Brian Cole of Midwest Orthopaedics at Rush University Medical Center is the inaugural 2017 recipient. The award’s namesake, Dr. Steven Gitelis, is one of…

AlloSource Business Process Manager Designated Malcolm Baldrige National Quality Award Examiner, Deepening Company’s Commitment To Performance Excellence

Centennial, Colo. — December 6, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures, recognized Kimberly Meyer, Business Process Manager, for being named to the Board of Examiners for the 2016 Malcolm Baldrige National Quality Award by the Commerce Department’s National Institute of Standards and Technology (NIST), deepening the organization’s commitment to process excellence. The Baldrige Award is the nation’s highest honor for organizational innovation and performance excellence. Appointed by the NIST Director, examiners are responsible for reviewing and evaluating applications submitted for the Baldrige Award, as…

TheraCell And AlloSource Announce Issuance Of Patent For Bone Fiber Technology

Northridge, Calif. and Centennial, Colo. — Oct. 25, 2016 — TheraCell, a regenerative medicine company, today announced that the United States Patent and Trademark Office (USPTO) will issue TheraCell a patent for its demineralized bone fiber (DBF™) technology. The addition of this patent expands TheraCell’s patent portfolio, demonstrating its ongoing commitment to innovation and leadership in the orthopedic allograft industry. TheraCell’s DBF technology is incorporated into two new innovative demineralized cortical fiber allografts, AlloFuse® Cortical Fibers and AlloFuse® Fiber Boats, provided by AlloSource®, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts. AlloFuse Cortical Fibers…

AlloSource Receives Phoenix Society For Burn Survivors’ Harman Award

Centennial, Colo. — October 21, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts to advance patient healing, received the Phoenix Society for Burn Survivors’ Harman Award for philanthropic leadership. The award is presented to an individual, family, corporation, foundation or service organization with a proven record of exceptional generosity through direct financial support and charitable responsibility. In 2013, AlloSource pledged an annual financial contribution to fund the Phoenix Society’s Educational Grant Program – the first and only national scholarship program created for burn survivor students. Over 163 students have received an…